Citigroup
PRQR icon

Citigroup’s ProQR Therapeutics PRQR Stock Holding History

Citigroup’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,724
Closed -$48.4K – 6369
2025
Q3 		$48.4K Buy
+22,724
New +$49.6K ﹤0.01% 4513
2023
Q1 		– Sell
-76
Closed -$281 – 5782
2022
Q4 		$281 Sell
76
-911
-92% -$1.19K ﹤0.01% 5565
2022
Q3 		$1K Sell
987
-276
-22% -$222 ﹤0.01% 5668
2022
Q2 		$1K Sell
1,263
-10,051
-89% -$7.49K ﹤0.01% 6074
2022
Q1 		$10K Sell
11,314
-4,585
-29% -$15.4K ﹤0.01% 5541
2021
Q4 		$127K Sell
15,899
-13,385
-46% -$102K ﹤0.01% 4611
2021
Q3 		$245K Sell
29,284
-4,891
-14% -$32K ﹤0.01% 4030
2021
Q2 		$230K Sell
34,175
-1,851,440
-98% -$11.9M ﹤0.01% 4173
2021
Q1 		$12.5M Buy
+1,885,615
New +$9.63M 0.01% 1238
2020
Q4 		– Sell
-3,964
Closed -$19K – 7571
2020
Q3 		$19K Buy
3,964
+95
+2% +$497 ﹤0.01% 6241
2020
Q2 		$24K Sell
3,869
-3,255
-46% -$17.6K ﹤0.01% 6483
2020
Q1 		$39K Buy
7,124
+3,296
+86% +$25.3K ﹤0.01% 6202
2019
Q4 		$38K Buy
3,828
+2,805
+274% +$21.8K ﹤0.01% 6533
2019
Q3 		$6K Buy
1,023
+120
+13% +$958 ﹤0.01% 7284
2019
Q2 		$8K Buy
903
+314
+53% +$3.7K ﹤0.01% 7368
2019
Q1 		$8K Buy
+589
New +$8.8K ﹤0.01% 7311
2015
Q4 		– Sell
-4
Closed – – 7799
2015
Q3 		$0 Buy
+4
New +$67 ﹤0.01% 7636

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Citigroup's PRQR Position: Q4 2025 in Review

Citigroup sold out of ProQR Therapeutics (PRQR) in Q4 2025, closing a stake of 22,724 shares — an estimated $48.4K sold.

Citigroup first reported a position in PRQR in Q3 2015 and held it in 17 quarters. The position peaked at $12.5M in Q1 2021. 65 funds tracked by Wall St. Rank hold PRQR as of Q4 2025.

  • Citigroup reported no remaining ProQR Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 22,724 ProQR Therapeutics shares in Q4 2025, an estimated $48.4K.
  • Citigroup first reported a position in ProQR Therapeutics in Q3 2015 and held it in 17 quarters.
  • Citigroup's ProQR Therapeutics position peaked at $12.5M in Q1 2021.
  • 65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.